SINOVAC BIOTECH LTD Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
SINOVAC BIOTECH LTD (SVA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $0 as of 2023-12-31, per its 20-F filed 2024-04-29.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2024-04-29
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $0.00.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value -$257.02K.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value -$257.02K.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $566.20K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value |
|---|---|
| 2023-12-31 | $0.00 20-F · filed 2024-04-29 |
| 2022-12-31 | -$257.02K 20-F · filed 2023-05-01 |
| 2021-12-31 | -$257.02K 20-F · filed 2022-04-29 |
| 2020-12-31 | $566.20K 20-F · filed 2021-04-22 |
| 2019-12-31 | $1.17M 20-F · filed 2020-04-30 |
| 2018-12-31 | $1.58M 20-F · filed 2019-04-29 |
| 2016-12-31 | $1.32B 20-F · filed 2017-11-22 |
| 2015-12-31 | $1.39B 20-F · filed 2016-04-25 |